West Pharmaceutical Services Inc (NYSE:WST)
| 337.89 Delayed Data As of 3:59pm ET |  -1.92 / -0.57%Today’s Change | 206.19 Today|||52-Week Range 424.00 | +43.57% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $24.8B |
Company Description
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Contact Information
West Pharmaceutical Services, Inc. 530 Herman O. West Drive Exton Pennsylvania 19341-0645 |
Employees
Shareholders
| Mutual fund holders | 57.29% |
| Individual stakeholders | 4.40% |
| Other institutional | 38.10% |
Top Executives
| Eric Mark Green | Chairman, President & Chief Executive Officer |
| Bernard J. Birkett | Senior VP, Chief Financial & Operations Officer |
| Silji Abraham | Chief Technology Officer & Senior Vice President |
| Annette F. Favorite | Chief Human Resources Officer & Senior VP |
| Kimberly Banks MacKay | Secretary, General Counsel & Senior Vice President |
